HNRNPF and neoplasm: Notably, iCAFs marked by TPM2 were enriched in the initial differentiation phase while myCAFs characterized by BIRC3, CCT6A, HNRNPF, and ID1 were enriched in the terminal differentiation phase during tumor progression.